Feedback Requested on Proposed Revisions to the BWC Formulary

The Bureau of Workers’ Compensation (BWC) is seeking comment from physicians on the proposed revisions to the BWC Formulary appendix to OAC 4123-6-21.3, the Outpatient Medication Formulary Rule. The language of the rule will not change except that the effective date will be December 1, 2015, for the changes described below. These proposed changes are the result of recommendations from our Pharmacy & Therapeutics Committee and reflect BWC’s dedication to providing for appropriate care while ensuring the safety of our injured workers. The committee’s recommendations resulted from consideration of current literature, accepted treatment guidelines and best clinical practice as well as FDA and information published by the drug manufacturers. 

Changes

The proposed changes to OAC 4123-6-21.3 pertain to Embeda®, Hysingla ER®, Zohydro ER®, Movantik®, Relistor®, Harvoni®, Noxafil®,Eliquis®, Savaysa®.

Injured workers who are impacted by any of these changes will be notified and given 60 days to work with their prescribers to make any necessary adjustments to their medication regimen. Likewise, any prescribers who are ordering these medications for injured workers will be notified of these formulary changes.

A “look-up” tool is available at http://www.ohiobwc.com/provider/default.asp.

How to submit feedback to BWC

Please submit your comments to Rxfeedback@bwc.state.oh.us and remember to include contact information with your name, phone number, email address and practice and/or specialty, if applicable. BWC will accept feedback through July 2, 2015. These proposed rule revisions will be submitted to the BWC Board of Directors’ Medical Services & Safety Committee for a first reading on Thursday, June 25, 2015. After reviewing the comments and feedback, we will provide the board with a final recommendation at its Medical Services & Safety Committee meeting on Thursday, July 23, 2015. If approved by the board, BWC will hold a public hearing and submit the revised rule to the Joint Committee on Agency Rule Review for a final review and incorporation into the OAC. 



The Pollen Line is now closed. See you in the spring!

Grass: 0
Mold: 0

Weed: 0

Tree: 0

Ragweed: 0

AMCNO on Twitter